Answers are grounded in this paper and cite their sources.
Few data on spontaneous clearance rates of cases of mother-to-child transmission of hepatitis C viral (HCV) infection are available in Japan. Furthermore, the treatment courses of interferon-based and direct-acting antiviral agent (DAA) therapies for children are also unclear. Our aim was thus to clarify the long-term natural progression of HCV infection and the treatment outcomes of children in Japan.
No takes yet. Share an insight, caveat, or question.
Nakano et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: